Product Program year 2021 Source: CMS Open Payments

PD-L1 IHC 22C3 pharmDx

Device pharmDx

PDI 05700571107300

Open in the dashboard

General payments

$2,929,893

29 payments

Research payments

$21,796

3 payments

Through program year 2021, $2,929,893 in general payments and $21,796 in research payments were reported against PD-L1 IHC 22C3 pharmDx (pharmDx).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $2,929,893 29
2021 Research $21,796 3

Breakdown

Who paid General payments · program year 2021
  1. Agilent Technologies, Inc. $2,929,893 29 payments
Top recipients General payments · program year 2021
  1. Dana-Farber Cancer Institute Teaching hospital · MA $1,749,057 60% · 6 payments
  2. Serge Alexanian Anatomic Pathology & Clinical Pathology · Los Angeles, CA $469,915 16% · 1 payment
  3. Joel Chan Anatomic Pathology & Clinical Pathology · Westlake Village, CA $72,825 2% · 1 payment
  4. Nam Ku Anatomic Pathology & Clinical Pathology · Los Angeles, CA $56,520 2% · 1 payment
  5. Regina Patricia Singson Anatomic Pathology & Clinical Pathology · Thousand Oaks, CA $52,150 2% · 1 payment

The top 5 of 17 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Anatomic Pathology & Clinical Pathology Pathology $1,089,939 94% · 13 practitioners
  2. Anatomic Pathology Pathology $74,897 6% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021
  1. Massachusetts $1,749,057 60% · 1 recipient
  2. California $1,164,835 40% · 15 recipients
  3. Washington $16,000 <1% · 1 recipient

Each share is of general payments naming this product in 2021 where a state was reported.

29 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record